These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16275090)

  • 1. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
    Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
    Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
    Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
    Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
    J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines.
    Kalla RV; Elzein E; Perry T; Li X; Gimbel A; Yang M; Zeng D; Zablocki J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1397-401. PubMed ID: 18226896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
    Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
    J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A(2B) receptor antagonists.
    Nieto MI; Balo MC; Brea J; Caamaño O; Cadavid MI; Fernández F; Mera XG; López C; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 May; 17(9):3426-32. PubMed ID: 19346133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-affinity relationships of adenosine A2B receptor ligands.
    Beukers MW; Meurs I; Ijzerman AP
    Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases.
    Elzein E; Kalla RV; Li X; Perry T; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    J Med Chem; 2008 Apr; 51(7):2267-78. PubMed ID: 18321039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
    Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
    Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A
    Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists.
    Esteve C; Nueda A; Díaz JL; Beleta J; Cárdenas A; Lozoya E; Cadavid MI; Loza MI; Ryder H; Vidal B
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3642-5. PubMed ID: 16697192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma.
    Zablocki J; Kalla R; Perry T; Palle V; Varkhedkar V; Xiao D; Piscopio A; Maa T; Gimbel A; Hao J; Chu N; Leung K; Zeng D
    Bioorg Med Chem Lett; 2005 Feb; 15(3):609-12. PubMed ID: 15664822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of spin-labeled probes for adenosine receptors.
    Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
    J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.
    Elzein E; Palle V; Wu Y; Maa T; Zeng D; Zablocki J
    J Med Chem; 2004 Sep; 47(19):4766-73. PubMed ID: 15341491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
    Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
    Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists.
    Nieto MI; Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Rodríguez-Borges JE; Vidal B
    Eur J Med Chem; 2010 Jul; 45(7):2884-92. PubMed ID: 20371139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
    Borrmann T; Hinz S; Bertarelli DC; Li W; Florin NC; Scheiff AB; Müller CE
    J Med Chem; 2009 Jul; 52(13):3994-4006. PubMed ID: 19569717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptors.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Moorman AR; Gessi S; Merighi S; Varani K; Borea PA
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3607-10. PubMed ID: 15177484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.